Insider · CIK 0001806431
Andrew Hykes
ceopresidentofficerdirector
Files at NARI (Inari Medical, Inc.), SI (SHOULDER INNOVATIONS, INC.). First filing Oct 31, 2024, latest Dec 20, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $468k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Inari Medical, Inc. | $166k 3,000 shares | -1% | - | |
| 24Weak | Inari Medical, Inc. | $152k 3,000 shares | -1% | - | |
| 24Weak | Inari Medical, Inc. | $150k 3,000 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SI SHOULDER INNOVATIONS, INC. | AGrant or award Common Stock | +669 | $19.60 | $13k | 7,438 | 6 d ago |
| Feb 19, 2025 | NARI Inari Medical, Inc. | UTender of shares Common Stockindirect: By Child 1 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | UTender of shares Common Stockindirect: By Child 2 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | UTender of shares Common Stockindirect: By Child 3 | -1,550 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | UTender of shares Common Stockindirect: By Spouse | -1,000 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | AGrant or award Common Stock | +20,393 | - | - | 717,637 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | UTender of shares Common Stock | -717,637 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | DDisposition to issuer Stock Options (Right to Buy)derivative | -36,085 | - | - | 0 | Feb 19, 2025 |
| Feb 19, 2025 | NARI Inari Medical, Inc. | DDisposition to issuer Stock Options (Right to Buy)derivative | -44,693 | - | - | 0 | Feb 19, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Common Stock | +161,100 | $0.43 | $69k | 663,806 | Feb 12, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Common Stock | +16,719 | $6.45 | $108k | 680,525 | Feb 12, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Common Stock | +16,719 | $0.46 | $7,639 | 697,244 | Feb 12, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Stock Options (Right to Buy)derivative | -161,100 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Stock Optionderivative | -16,719 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | NARI Inari Medical, Inc. | MOption exercise Stock Optionderivative | -16,719 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 4, 2025 | NARI Inari Medical, Inc. | AGrant or award Common Stock | +67,282 | $0.00 | $0 | 502,706 | Feb 6, 2025 |
| Jan 1, 2025 | NARI Inari Medical, Inc. | FTax withholding Common Stock | -509 | $51.05 | $26k | 438,801 | Jan 3, 2025 |
| Jan 1, 2025 | NARI Inari Medical, Inc. | FTax withholding Common Stock | -949 | $51.05 | $48k | 437,852 | Jan 3, 2025 |
| Jan 1, 2025 | NARI Inari Medical, Inc. | FTax withholding Common Stock | -1,632 | $51.05 | $83k | 436,220 | Jan 3, 2025 |
| Jan 1, 2025 | NARI Inari Medical, Inc. | FTax withholding Common Stock | -1,319 | $51.05 | $67k | 434,901 | Jan 3, 2025 |
| Dec 20, 2024 | NARI Inari Medical, Inc. | SOpen-market sale Common Stock10b5-1 | -2,400 | $55.20 | $132k | 439,910 | Dec 20, 2024 |
| Dec 20, 2024 | NARI Inari Medical, Inc. | SOpen-market sale Common Stock10b5-1 | -600 | $55.65 | $33k | 439,310 | Dec 20, 2024 |
| Nov 20, 2024 | NARI Inari Medical, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $50.83 | $152k | 442,310 | Nov 22, 2024 |
| Oct 29, 2024 | NARI Inari Medical, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $50.00 | $150k | 445,310 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.